Advertisement

Topics

Quarterly Co. Company Profile

17:03 EST 9th December 2018 | BioPortfolio

Quarterly Co.™ is a subscription service that sends people curated, physical gifts in the mail every three months from influential contributors of their choice. Founded in 2011, Quarterly is currently backed by True Ventures, Collaborative Fund, VegasTechFund, SV Angel and others. For more information, visit www.quarterly.co.


News Articles [61 Associated News Articles listed on BioPortfolio]

What the Aurora Cannabis Quarterly Report Means for the Future of the Pot Industry

Aurora Cannabis Quarterly Report The first wave of quarterly reports post-legalization are set to roll in, and Aurora Cannabis Inc (NYSE:ACB) is leading the way. The Aurora quarterly report came in...

Mesa Labs Declares Quarterly Dividend

Lakewood, Colorado, July 09, 2018 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared...

HEI Maintains Quarterly Dividend Of $0.31 Per Share

HONOLULU, Aug. 2, 2018 /PRNewswire/ -- On August 1, 2018, the Board of Directors of Hawaiian Electric Industries, Inc. (HEI) (NYSE: HE) maintained HEI's quarterly Read more...

Wolverine Worldwide Declares Quarterly Dividend

ROCKFORD, Mich., Aug. 1, 2018 /PRNewswire/ -- Wolverine World Wide, Inc. (NYSE: WWW) today announced that its Board of Directors has declared a quarterly cash Read more...

Medibio Quarterly ASX Update and Cashflows

Medibio (ASX:MEB; OTCQB:MDBIF), a mental health technology company provides the following quarterly update. As quoted in the press release: The FDA review process continues to move forward as anticipa...

S P Global Declares Quarterly Dividend

NEW YORK, Oct. 29, 2018 /PRNewswire/ -- The Board of Directors of S&P Global (NYSE: SPGI) has approved a regular quarterly cash dividend on the Read more...

Biogen quarterly sales rise 9 percent

Biogen Inc reported a 9 percent rise in quarterly revenue on Tuesday, helped by demand for its spinal muscular atrophy drug Spinraza.

Roche Quarterly Financials: "Firing on All Cylinders"

Roche announced a strong second quarterly report with a 7 percent increase in group sales for the first half of the year and a 20 percent increase in its core earnings per share (EPS).

PubMed Articles [149 Associated PubMed Articles listed on BioPortfolio]

OzFoodNet quarterly report, 1 July to 30 September 2015.

The Australian Government Department of Health established the OzFoodNet network in 2000 to collaborate nationally to investigate foodborne disease. In each Australian state and territory, OzFoodNet e...

From the Editor.

Literature Reviews.

From the Editor.

Literature Reviews.

Clinical Trials [55 Associated Clinical Trials listed on BioPortfolio]

Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa

The objective of the study is to evaluate the feasibility and interest of a HIV quarterly preventive global care for men who have sex with men (MSM) in sub-Saharan Africa to help reducing ...

A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic

The purpose of this study is to determine if remote monitoring of implantable cardioverter defibrillators (ICD), compared with quarterly device interrogations in clinic, will improve patie...

Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty

A multicenter, open-label, prospective study to evaluate the safety and efficacy of leuprorelin acetate DPS (Leuplin DPS) treatment quarterly in patients with central precocious puberty

A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

This single arm study will assess the efficacy and safety of quarterly intravenous Bonviva in women with post-menopausal osteoporosis. All patients will receive Bonviva 3mg i.v. every 3 mo...

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

The primary objective of the study is to evaluate the safety and tolerability of treatment with PROVIGIL in children and adolescents with excessive sleepiness (ES) associated with narcolep...

Companies [35 Associated Companies listed on BioPortfolio]

Quarterly Co.

Quarterly Co.™ is a subscription service that sends people curated, physical gifts in the mail every three months from influential contributors of their choice. Founded in 20...

Vision.org

Vision.org is an online magazine with quarterly print issues covering a variety of social, philosophical, moral and ethical issues. For a free subscription to Vision’s...

Vision Media Publishing

Vision.org is an online magazine with quarterly print issues that feature in-depth articles covering current events, social issues, environmental issues, family relationshi...

Congressional Quarterly

HealthLeaders-InterStudy

Health Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly and ...

More Information about "Quarterly Co." on BioPortfolio

We have published hundreds of Quarterly Co. news stories on BioPortfolio along with dozens of Quarterly Co. Clinical Trials and PubMed Articles about Quarterly Co. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Quarterly Co. Companies in our database. You can also find out about relevant Quarterly Co. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record